Medication info
Baisib Tablets 10/10 mg

Baisib Tablets 10/10 mg

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›10mg / 1 tablet
Manufacturer / importer
Celltrion Pharmaceutical Co., Ltd.
Appearance
A white to light yellow, double convex, rectangular tablet
Packaging
30 tablets (10 tablets/PTP packaging x 3)
Approval status
Active

MFDS item code 201601731 · Approved 2016.03.31 · Insurance code 693902150

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dosage should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Take this medicine once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range is 10/10 mg to 10/40 mg once daily. The generally recommended starting dose is 10/20 mg once daily. Patients who require less LDL cholesterol reduction may start with 10/10 mg once daily. After starting treatment or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of at least 4 weeks. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40 mg once daily, taken in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration in patients with hepatic impairment No dosage adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function, under Precautions for Use). Administration in patients with renal impairment and patients with chronic kidney disease No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20 mg once daily in the evening. Use caution and carefully monitor these patients when administering higher doses of this medicine (see 5. General Precautions under Precautions for Use). Administration in elderly patients No dosage adjustment is necessary in elderly patients. Concomitant use with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients taking this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10 mg/day of this medicine. Patients taking this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20 mg/day of this medicine.

Ingredients

Manufacturer
Celltrion Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • increased risk of atherosclerotic vascular disease due to hypercholesterolemia
  • dyslipidemia.
View approved original text

This medication effectively lowers cholesterol and triglyceride levels in patients with primary hypercholesterolemia and mixed hyperlipidemia, and helps raise levels of good cholesterol (HDL). It is used in combination with a diet for patients with familial hypercholesterolemia or as an adjuvant therapy when other treatments are not effective. Additionally, it supports cardiovascular health when used with appropriate dietary management in patients at high risk for atherosclerotic vascular disease. Before use, one should evaluate for underlying secondary causes such as diabetes and hypothyroidism, and treat those conditions if necessary. To assess treatment efficacy, cholesterol and triglyceride levels should be monitored regularly. In summary, this drug is used for treating hypercholesterolemia and helps improve blood lipid levels.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dosage should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Take this medicine once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range is 10/10 mg to 10/40 mg once daily. The generally recommended starting dose is 10/20 mg once daily. Patients who require less LDL cholesterol reduction may start with 10/10 mg once daily. After starting treatment or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of at least 4 weeks. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40 mg once daily, taken in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration in patients with hepatic impairment No dosage adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function, under Precautions for Use). Administration in patients with renal impairment and patients with chronic kidney disease No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20 mg once daily in the evening. Use caution and carefully monitor these patients when administering higher doses of this medicine (see 5. General Precautions under Precautions for Use). Administration in elderly patients No dosage adjustment is necessary in elderly patients. Concomitant use with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients taking this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10 mg/day of this medicine. Patients taking this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20 mg/day of this medicine.

Precautions

This drug has the potential to cause muscle-related disorders such as myopathy and rhabdomyolysis. Myopathy may present with muscle pain and weakness, and in severe cases, may lead to renal damage, thus caution is warranted. The risk is particularly heightened when taken at high doses or in conjunction with certain medications. This drug should not be used in patients who are allergic to its ingredients, severely impaired liver function, pregnant or breastfeeding women. Additionally, patients with a genetic problem concerning lactose in this drug should not take it. Patients with severe muscle weakness or ocular myasthenia gravis should use this drug cautiously and discontinue immediately if symptoms worsen. Patients on this medication should consult their doctor immediately if they experience muscle pain, weakness, tenderness, etc., and should verify their condition through muscle enzyme tests if necessary. Patients with liver dysfunction should have regular liver function tests before and during the use of this drug; if liver damage symptoms arise, administration should be halted immediately. This drug may interact with several other medications, so if you are taking other medications, you must inform your doctor or pharmacist. The risk of myopathy increases when used with specific antifungals, antibiotics, antivirals, anticoagulants, calcium channel blockers, thus caution is advised. Women who are planning to become pregnant or are of childbearing potential must consult healthcare professionals before taking this drug, and should discontinue immediately if pregnancy is confirmed. Women who are breastfeeding should also refrain from nursing while taking this drug. For children and adolescents, sufficient data regarding safety and efficacy of this drug is lacking, thus it is not recommended for children under 10 years of age. Elderly patients require special caution and should discuss potential adverse reactions with healthcare professionals. In cases of overdose, there is no specific antidote, so one must seek immediate medical care for appropriate treatment. This drug may cause rare respiratory side effects like interstitial lung disease during long-term use. Therefore, if difficulty breathing or persistent cough occurs, consult a doctor immediately. Lastly, it is important to monitor liver function and muscle condition through regular blood tests and clinical assessments during the course of this treatment.

Side effects

Myopathy, rhabdomyolysis, elevated creatine kinase, headache, diarrhea, influenza, upper respiratory infection, myalgia, limb pain, fatigue, abdominal pain, viral infection, pharyngitis, sinusitis, arthralgia, back pain, cough, anaphylaxis, urticaria, rash, angioedema, elevated liver aminotransferase levels, hepatitis, thrombocytopenia, nausea, pancreatitis, dizziness, sensory abnormalities, depression, cholelithiasis, cholecystitis, mucocutaneous syndrome, toxic epidermal necrolysis, eosinophilia, systemic symptom-associated drug reactions, erythema multiforme, myasthenia, cataract, constipation, dyspepsia, flatulence, nausea, eczema, pruritus, rash, muscle cramps, specific cranial nerve dysfunction, dysgeusia, oculomotor abnormalities, facial paralysis, tremor, peripheral neuropathy, peripheral nerve palsy, psychiatric disorders, anxiety, sleep disorders, memory decline, amnesia, memory loss, memory impairment, confusion, interstitial lung disease, angioedema, lupus-like erythematosus syndrome, rheumatic polymyalgia, dermatomyositis, vasculitis, purpura, leukopenia, hemolytic anemia, positive antinuclear antibody, increased erythrocyte sedimentation rate, arthritis, photosensitivity, fever, chills, flushing, malaise, dyspnea, cholestatic jaundice, hepatic steatosis, cirrhosis, fulminant hepatic necrosis, liver cancer, alopecia, various skin changes, lichenoid drug eruption, gynecomastia, decreased libido, sexual dysfunction, ocular muscle paralysis, anemia, elevated aminotransferase levels, increased ALP, elevated gamma-GT, increased bilirubin levels, thyroid dysfunction, increased serum creatine kinase, abnormal liver function tests, increased HbA1c, elevated fasting blood glucose levels, edema, thirst, facial swelling, syncope, insomnia, gastritis, atrophic gastritis, mucous stools, irritable bowel syndrome, sore throat, nocturia, hematuria, weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This drug is sensitive to air and moisture, so it should be stored in a sealed container. The recommended storage temperature is between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

A white to light yellow, double convex, rectangular tablet

Package unit

30 tablets (10 tablets/PTP packaging x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.